6.
Galli L, Chiappini E, de Martino M
. Infections and autoimmunity. Pediatr Infect Dis J. 2012; 31(12):1295-7.
DOI: 10.1097/INF.0b013e3182757c4d.
View
7.
Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J
. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16):1526-33.
DOI: 10.1056/NEJMoa021933.
View
8.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P
. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607-1608.
PMC: 7204765.
DOI: 10.1016/S0140-6736(20)31094-1.
View
9.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M
. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; 395(10239):1771-1778.
PMC: 7220177.
DOI: 10.1016/S0140-6736(20)31103-X.
View
10.
McMurray J, May J, Cunningham M, Jones O
. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment. Front Pediatr. 2021; 8:626182.
PMC: 7793714.
DOI: 10.3389/fped.2020.626182.
View
11.
Bartsch Y, Wang C, Zohar T, Fischinger S, Atyeo C, Burke J
. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021; 27(3):454-462.
PMC: 8315827.
DOI: 10.1038/s41591-021-01263-3.
View
12.
Carter M, Fish M, Jennings A, Doores K, Wellman P, Seow J
. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020; 26(11):1701-1707.
DOI: 10.1038/s41591-020-1054-6.
View
13.
Lee P, Day-Lewis M, Henderson L, Friedman K, Lo J, Roberts J
. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020; 130(11):5942-5950.
PMC: 7598077.
DOI: 10.1172/JCI141113.
View
14.
Shulman S
. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome. J Pediatric Infect Dis Soc. 2020; 9(3):285-286.
PMC: 7313948.
DOI: 10.1093/jpids/piaa062.
View
15.
Sharma C, Ganigara M, Galeotti C, Burns J, Berganza F, Hayes D
. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. 2021; 17(12):731-748.
PMC: 8554518.
DOI: 10.1038/s41584-021-00709-9.
View
16.
Diorio C, McNerney K, Lambert M, Paessler M, Anderson E, Henrickson S
. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020; 4(23):6051-6063.
PMC: 7724906.
DOI: 10.1182/bloodadvances.2020003471.
View
17.
Kaushik S, Aydin S, Derespina K, Bansal P, Kowalsky S, Trachtman R
. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 2020; 224:24-29.
PMC: 7293760.
DOI: 10.1016/j.jpeds.2020.06.045.
View
18.
Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M
. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. JAMA. 2021; 325(9):855-864.
PMC: 7851757.
DOI: 10.1001/jama.2021.0694.
View
19.
Nakra N, Blumberg D, Herrera-Guerra A, Lakshminrusimha S
. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children (Basel). 2020; 7(7).
PMC: 7401880.
DOI: 10.3390/children7070069.
View
20.
Martinez-Garcia J, Lopez-Acosta J, Arce-Cabrera D, Leon-Sicairos N, Hernandez-Parra A, Cuen-Diaz H
. Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease. Front Pediatr. 2023; 11:1167828.
PMC: 10149839.
DOI: 10.3389/fped.2023.1167828.
View